荷兰人群脑膜炎球菌ACWY抗体血清流行病学:2016/17与2020年两次连续调查
在荷兰2016/17年全国横断面血清调查(0-89岁,n=6886)及2020年纵向样本(n=1782)中检测脑膜炎球菌ACWY多糖特异性IgG。MenC抗体水平总体低,仅近期接种的14-23月龄儿童(59%)和2002年青少年时期接种者(20-46%)血清阳性率较高;AWY抗体水平在两次调查中均低,2020年自然获得的MenW免疫力有限,尽管近期发生W群疫情。
要点
- MenC抗体水平总体低,仅近期接种的14-23月龄儿童血清阳性率59%,2002年青少年接种者20-46%。
- 脑膜炎球菌AWY抗体水平在2016/17和2020年均总体低。
- 2020年自然获得的MenW免疫力有限,尽管近期发生W群疫情。
核心结论
- 本研究显示荷兰大规模接种活动15年后MenC免疫力减弱,并强调人群脑膜炎球菌AWY免疫力缺乏及近期引入MenACWY(加强)接种的重要性。
研究设计与样本
- 2016/17年全国横断面血清调查,参与者0-89岁(n=6886),检测MenACWY多糖特异性血清IgG浓度,并在部分亚组测定功能性MenACWY抗体滴度。
- 2020年收集纵向样本(n=1782),检测MenACWY多糖特异性血清IgG浓度。
主要发现
- MenC抗体水平低,除外近期接种的14-23月龄儿童(血清阳性率59%)和2002年青少年时期接种者(血清阳性率20-46%)。
- 脑膜炎球菌AWY抗体水平在2016/17和2020年均总体低。
- 2020年自然获得的MenW免疫力有限,尽管近期发生W群疫情。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningococcal serogroup C (MenC) vaccination was introduced for 14-month-olds in the Netherlands in 2002, alongside a mass campaign for 1-18 year-olds. Due to an outbreak of serogroup W disease, MenC vaccination was replaced for MenACWY vaccination in 2018, next to introduction of a booster at 14 years of age and a catch-up campaign for 14-18 year-olds. We assessed meningococcal ACWY antibodies across the Dutch population in 2016/17 and 2020. METHODS: In a nationwide cross-sectional serosurvey in 2016/17, sera from participants aged 0-89 years (n = 6886) were tested for MenACWY-polysaccharide-specific (PS) serum IgG concentrations, and functional MenACWY antibody titers were determined in subsets. Moreover, longitudinal samples collected in 2020 (n = 1782) were measured for MenACWY-PS serum IgG concentrations. RESULTS: MenC antibody levels were low, except in recently vaccinated 14-23 month-olds and individuals who were vaccinated as teenagers in 2002, with seroprevalence of 59% and 20-46%, respectively. Meningococcal AWY antibody levels were overall low both in 2016/17 and in 2020. Naturally-acquired MenW immunity was limited in 2020 despite the recent serogroup W outbreak. CONCLUSIONS: This study demonstrates waning of MenC immunity 15 years after a mass campaign in the Netherlands. Furthermore, it highlights the lack of meningococcal AWY immunity across the population and underlines the importance of the recently introduced MenACWY (booster) vaccination.
引用
- Ohm M, Knol MJ, Vos ERA, et al. Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020. Vaccine. 2021. PMID: 34839991. doi:10.1016/j.vaccine.2021.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。